Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

M. R. Naber, A.E van der Meulen, P. W. Voorneveld, S. H. C. Veltkamp, A.A. van Bodegraven, A. Bodelier, Z. Mujagic, M. Pierik, L. M. M. Verleye, M. Duijvestein, D. G. Bouwknegt, M. C. Visschedijk, N. Srivastava, R. L. West, B. Oldenburg, M. Löwenberg, F.D.M. van Schaik, Unknown

Open source

DOI: 10.1002/ueg2.70141
Published: 2025-12-05
Container: United European Gastroenterology Journal
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ueg2.70141,
  title = {Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry},
  author = {M. R. Naber and A.E van der Meulen and P. W. Voorneveld and S. H. C. Veltkamp and A.A. van Bodegraven and A. Bodelier and Z. Mujagic and M. Pierik and L. M. M. Verleye and M. Duijvestein and D. G. Bouwknegt and M. C. Visschedijk and N. Srivastava and R. L. West and B. Oldenburg and M. Löwenberg and F.D.M. van Schaik and Unknown},
  year = {2025},
  journal = {United European Gastroenterology Journal},
  doi = {10.1002/ueg2.70141},
  url = {https://doi.org/10.1002/ueg2.70141}
}

RIS

TY  - JOUR
TI  - Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry
AU  - M. R. Naber
AU  - A.E van der Meulen
AU  - P. W. Voorneveld
AU  - S. H. C. Veltkamp
AU  - A.A. van Bodegraven
AU  - A. Bodelier
AU  - Z. Mujagic
AU  - M. Pierik
AU  - L. M. M. Verleye
AU  - M. Duijvestein
AU  - D. G. Bouwknegt
AU  - M. C. Visschedijk
AU  - N. Srivastava
AU  - R. L. West
AU  - B. Oldenburg
AU  - M. Löwenberg
AU  - F.D.M. van Schaik
AU  - Unknown
PY  - 2025
JO  - United European Gastroenterology Journal
DO  - 10.1002/ueg2.70141
UR  - https://doi.org/10.1002/ueg2.70141
ER  -

APA

Naber, M. R., Meulen, A. V. D., Voorneveld, P. W., Veltkamp, S. H. C., Bodegraven, A. V., Bodelier, A., Mujagic, Z., Pierik, M., Verleye, L. M. M., Duijvestein, M., Bouwknegt, D. G., Visschedijk, M. C., Srivastava, N., West, R. L., Oldenburg, B., Löwenberg, M., Schaik, F. V., & Unknown (2025). Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70141

Source records

crossref · retrieved 2026-09-26T10:00:35.815Z